Furthermore, our observations through IHC staining indicated that MZ1 treatment significantly inhibited the expression of BRD4 and the proliferation marker Ki-67 in tumor tissues, in comparison to the control group (Fig. 5e). Here, BRD4 is linked to neoplasm.